Marinus Pharmaceuticals, Inc.
5 Radnor Corporate Center, Suite 500
100 Matsonford Rd
Radnor, PA 19087
July 20, 2020
VIA EDGAR
Office of Life Sciences
Division of Corporation Finance
U.S. Securities and Exchange Commission
100 F Street, NE
Washington, DC 20549
Attn: Jeffrey Gabor
Re: Marinus Pharmaceuticals, Inc.
Registration Statement on Form S-3
Filed July 9, 2020
File No. 333-239780
Request for Acceleration of Effective Date
Ladies and Gentlemen:
On July 16, 2020, Marinus Pharmaceuticals, Inc. (the “Company”) requested acceleration of the effective date and time of the above-referenced Registration Statement on Form S-3 for Monday, July 20, 2020, at 4:00 PM, Eastern Time, or as soon as possible thereafter. The Company hereby withdraws such acceleration request until further notice.
Please feel free to direct any questions or comments concerning this request to Steve Abrams of Hogan Lovells US LLP at (267) 675-4671.
| Very truly yours, | |
| Marinus Pharmaceuticals, Inc. |
/s/ Edward F. Smith | ||
| By: | Edward F. Smith | |
| Title: | Vice President, Chief Financial Officer, Secretary and Treasurer | |
